Modifying gut bacteria with oral sialic acid in healthy adults
Official title: Modulation of Gut Microbiota by Oral Sialic Acid: A Mechanistic Study
Run by Army Medical University, China · NCT07162662 · Data updated 2026-11-12
We are testing whether taking oral sialic acid changes the gut microbiome in healthy adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 42 (estimated) |
| Sponsor | Army Medical University, China Academic / other |
| Locations | 1 site (Chongqing, Chongqing Municipality) |
| Status | Recruiting |
| Started | September 10, 2025 |
| Main results expected | August 1, 2026 |
| Study ends | August 1, 2027 |
| Registry record updated | December 10, 2025 |
| Trial ID | NCT07162662 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy adults aged 18–75 with no major medical conditions, no recent use of antibiotics/probiotics/immunosuppressants, and willing to sign informed consent are the intended participants.
✕Probably not a fit
People with serious comorbidities, recent severe infections or anti-infective treatment, pregnant or lactating women, or those unable to follow the protocol are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center prospective cohort gives oral sialic acid to healthy volunteers and monitors changes in their gut microbiota over time. Stool samples will be collected serially and analyzed (e.g., sequencing and microbial quantification) with particular attention to growth of pathogens such as Escherichia coli and Klebsiella pneumoniae. Participants are aged 18–75, must be free of major diseases and recent antibiotics, and will be followed according to a predefined protocol. The goal is to clarify how sialic acid intake affects intestinal microbial structure and to inform strategies to preserve or restore intestinal homeostasis.
Why it matters
Potential benefit: If successful, this work could identify how sialic acid intake shifts gut bacteria and suggest ways to prevent pathogen overgrowth and protect intestinal healing.
How similar studies have gone: Preclinical and observational studies suggest sialic acid can feed certain gut pathogens, but controlled human interventional data on oral sialic acid are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged between 18 and 75 years * No history of major diseases, no previous surgical history, and no history of cardiometabolic diseases (such as hypertension, diabetes mellitus, obesity, etc.) * No use of drugs that may affect gut microbiota or metabolic function (e.g., antibiotics, probiotics, immunosuppressants, etc.); * Voluntarily participate in the study and sign the informed consent form. Exclusion Criteria: * Comorbidities: Complicated with other severe diseases (e.g., immunodeficiency, chronic liver disease, renal insufficiency, malignant tumors, etc.). * Recent infections: Registration records indicate a history of severe infections in the recent period (within 3 months) or currently receiving anti-infective treatment. * Special populations: Pregnant women, lactating women, or women planning to become pregnant. * Poor compliance: Volunteers who are unable to cooperate with the study protocol or follow-up
Where it's running
-
Second Affiliated Hospital of Army Medical University
Chongqing, Chongqing Municipality, China Recruiting
Study contacts
- Study coordinator: Xiaolong Li, MD
- Email: 917304077@qq.com
- Phone: +86 15025326575
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?
This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
-
Miricell supplementation and markers of healthy aging
This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.
-
Does daily lean beef support brain health in older adults
In healthy adults aged 65 and up, this study tests whether eating lean beef every day for two weeks can influence brain health markers compared with a non-beef, protein-matched option.
-
Adaptive computerized training to boost thinking in healthy seniors and those with mild cognitive impairment
This study tests whether a computer-based training program can improve executive thinking in older adults, including those with mild cognitive impairment, and see if it also helps memory and well-being.
-
SHARP: Personalized Health and Behavior Plan to Lower Biological Age in Older Adults
A 12-month randomized trial tests whether a personalized health and behavior program can lower biological age and improve function in healthy adults over 50.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.